/healthcare-authority/deals-corporate-governance?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Healthcare Authority Deals & Corporate Governance Copyright 2025 ¼«ËÙÈü³µ. en-US Fri, 18 Apr 2025 16:14:50 +0000 /healthcare-authority/deals-corporate-governance/articles/2326949?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2326949 The nation's "Big Three" pharmacy benefit managers are asking the Eighth Circuit to pause the Federal Trade Commission's in-house insulin price-fixing case against them, saying that their constitutional challenge to the commission's administrative proceeding process should be fully heard before the in-house case moves forward. Thu, 17 Apr 2025 23:37:38 +0000 /healthcare-authority/deals-corporate-governance/articles/2327132?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2327132 Novartis must produce certain privileged documents to Incyte concerning its understanding of their contract for royalty payments from sales of Incyte's blood cancer drug, unless Novartis agrees its former outside counsel, who negotiated the terms, won't testify about that topic at the upcoming contract breach trial, a New York federal judge said Thursday. Thu, 17 Apr 2025 18:30:35 +0000 /healthcare-authority/deals-corporate-governance/articles/2326962?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2326962 A North Carolina Business Court judge rejected HCA Healthcare's bid for a partial win in state Attorney General Jeff Jackson's compliance suit reviewing the company's 2019 purchase of another hospital system, ruling that the purchase agreement's language is too ambiguous to decide the matter without further discovery. Thu, 17 Apr 2025 16:08:13 +0000 /healthcare-authority/deals-corporate-governance/articles/2326581?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2326581 Autoimmune disease therapeutics company Zenas BioPharma Inc. was hit with a proposed shareholder class action alleging that its registration statement for its September 2024 initial public offering overstated the amount of time that the company could fund its operations using existing cash and expected net proceeds from the offering. Wed, 16 Apr 2025 20:39:16 +0000 /healthcare-authority/deals-corporate-governance/articles/2325970?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2325970 Executives and directors of glucose monitor manufacturer DexCom Inc. have been hit with a derivative suit alleging that they concealed from investors that DexCom struggled to maintain a sales force that could keep up with growing demand following a Medicare policy expansion. Tue, 15 Apr 2025 22:05:08 +0000 /healthcare-authority/deals-corporate-governance/articles/2325634?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2325634 A hospital trade group urged the Ninth Circuit on Monday to block an Oregon law allowing the Oregon Health Authority to review proposed healthcare business consolidations, arguing the law is "unconstitutionally vague" and bestows unlimited power on the agency to block healthcare transactions in the state. Tue, 15 Apr 2025 19:48:52 +0000 /healthcare-authority/deals-corporate-governance/articles/2325201?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2325201 As tariffs loom on the horizon, Big Pharma companies laud their plans to ramp up U.S. manufacturing — even as they're set to eat costs for the foreseeable future. Tue, 15 Apr 2025 16:15:01 +0000 /healthcare-authority/deals-corporate-governance/articles/2325692?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2325692 McGuireWoods LLP and a former partner have told a North Carolina state appeals court that they have absolute privilege over allegedly defamatory statements made in connection with an investigation into the former CEO of a managed care organization, arguing that the trial court should have granted them a pretrial win. Tue, 15 Apr 2025 11:26:00 +0000 /healthcare-authority/deals-corporate-governance/articles/2325501?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2325501 Healthcare-focused private equity shop Linden Capital Partners, advised by Kirkland & Ellis LLP, on Tuesday announced that it clinched its sixth fund with $5.4 billion of capital commitments. Fri, 11 Apr 2025 21:54:51 +0000 /healthcare-authority/deals-corporate-governance/articles/2324688?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324688 The Consumer Financial Protection Bureau said Friday that it will scrap recent guidance aimed at reining in medical debt collectors and may close out its new national nonbank enforcement registry, extending the agency's pullback from its Biden-era policies. Fri, 11 Apr 2025 20:11:30 +0000 /healthcare-authority/deals-corporate-governance/articles/2324115?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324115 Executives and directors of dental supply manufacturing company Dentsply Sirona Inc. have been hit with a derivative suit alleging they concealed that a company subsidiary was approving unsuitable patients for dental treatments to inflate sales figures. Fri, 11 Apr 2025 19:48:24 +0000 /healthcare-authority/deals-corporate-governance/articles/2324439?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324439 The North Carolina Attorney General's Office can't shield a host of internal records pertaining to its review of a 2019 hospital merger at the center of a compliance case, a state court judge has said, finding "only a few" records constitute protected attorney-client communications or work product. Fri, 11 Apr 2025 19:27:14 +0000 /healthcare-authority/deals-corporate-governance/articles/2324531?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324531 Kidney-focused biotech Aurinia Pharmaceuticals Inc. on Friday launched a lawsuit in New Jersey federal court claiming that Lotus Pharmaceutical Co. Ltd.'s bid to sell a generic form of Aurinia's lupus nephritis treatment Lupkynis infringes a pair of patents. Fri, 11 Apr 2025 17:28:16 +0000 /healthcare-authority/deals-corporate-governance/articles/2324154?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324154 The Fifth Circuit has revived Zyla Life Sciences LLC's lawsuit seeking to block Texas rival Wells Pharma from selling rheumatoid arthritis drug suppositories that aren't U.S. Food and Drug Administration-approved, rejecting Wells Pharma's argument that Zyla's state claims are preempted under federal law and noting that finding otherwise would have "staggering" implications. Fri, 11 Apr 2025 16:58:29 +0000 /healthcare-authority/deals-corporate-governance/articles/2324505?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2324505 Pharmaceutical manufacturer and packager Future Pak LLC, advised by Honigman LLP, on Friday publicly unveiled its proposal to acquire pharmaceutical company Theratechnologies Inc. for up to $255 million, a move that comes after Future Pak has received "minimal engagement" from the other company. Tue, 08 Apr 2025 21:03:19 +0000 /healthcare-authority/deals-corporate-governance/articles/2322005?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2322005 The former operator of a now-bankrupt Iowa hospital is facing scrutiny over allegations the hospital suffered massive operating losses while paying some $9 million to the operator in fees in the years before its financial collapse. Tue, 08 Apr 2025 18:47:28 +0000 /healthcare-authority/deals-corporate-governance/articles/2322091?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2322091 Hopes for an improving healthcare public market all but vanished after a sweeping tariffs announcement from Washington set off a wave of market volatility. Tue, 08 Apr 2025 18:21:05 +0000 /healthcare-authority/deals-corporate-governance/articles/2322541?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2322541 Pacira BioSciences has agreed to settle a series of patent infringement lawsuits against Fresenius Kabi and other pharmaceutical companies over Pacira's drug Exparel, a long-acting injectable for managing postsurgical pain. Tue, 08 Apr 2025 18:17:56 +0000 /healthcare-authority/deals-corporate-governance/articles/2322121?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2322121 A North Carolina federal judge has pared HCA Healthcare Inc.'s subpoenas to a hospital network in a consolidated antitrust case accusing it of hiking Tar Heel State public employees' health insurance costs, putting a two-hour time limit on the depositions it sought and cutting three years of requested information. Tue, 08 Apr 2025 16:51:26 +0000 /healthcare-authority/deals-corporate-governance/articles/2322079?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2322079 The life sciences industry escaped much of the immediate impact of President Donald Trump's market-shaking tariff order, thanks to the inclusion of a single word on an exemption list — "pharmaceuticals." The relief may not last long.